crowdreviews.com

Strategic Partner

May 16, 2018 - May 17, 2018

Annual Pharmaceutical Biotechnology Congress (Pharma Biotech Congress 2018)

Singapore

Map Event Location Share this Event

Event Details

Begins: May 16, 2018

End: May 17, 2018

Event Location: Singapore

Website: https://pharmbiote..ences.com

Event Organizer

Event Organizer: Conference Series

Contact Person: Michael Bay

Phone Number: 1-702-508-5200 x 8045

Website: https://www.conferenceseries.com/

Overview

Conferenceseries LLC proudly announces the commencement of “Annual Pharmaceutical Biotechnology Congress” which is going to be held during May 16-17, 2018 at Singapore.

Pharma Biotech Congress 2018 focuses upon “Latest Research and Development Trends for optimum solutions in the Field”.  This Pharma Biotech Congress 2018 focuses on the trends which the biopharmaceutical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market.

Why to attend???

Join your peers around the world focused on learning about Biopharmaceutics, Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biopharma community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference.


BECOME A STRATEGIC PARTNER

We are looking to build strategic relationships with conference and event organizers paving the way for industry advancements and education.